Jaundice as a prognostic factor in patients undergoing radical treatment for carcinomas of the ampulla of Vater

Chinese Medical Journal

Volumn 127, Issue 5, 2014, Pages 860-864

  Zhou, Jian Guo ^a   Zhang, Qian ^b   Li, Peng ^a   Shan, Yi ^a   Zhao, Dong Bing ^a   Cai, Jian Qiang ^a  

^a CANCER HOSPITAL   (China)

^b AEROSPACE CENTRAL HOSPITAL   (China)

Author keywords

Ampulla of Vater; Carcinoma; Jaundice; Prognosis

Indexed keywords

CA 19-9 ANTIGEN; CAPECITABINE; CAPECITABINE PLUS OXALIPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; OXALIPLATIN;

ABDOMINAL INFECTION; ADULT; AGED; ANASTOMOSIS; ARTICLE; BILE LEAKAGE; BILIRUBIN BLOOD LEVEL; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; JAUNDICE; LUNG INFECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS METASTASIS; PANCREATICODUODENECTOMY; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; STOMACH EMPTYING; TUMOR DIFFERENTIATION; TUMOR VOLUME; VATER PAPILLA CARCINOMA; COMMON BILE DUCT NEOPLASMS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; VATER PAPILLA;

ADULT; AGED; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAUNDICE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY;

EID: 84896845698     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20132461     Document Type: Article

References (20)

1. Neugut AI, Jacobson JS, Rella VA. Prevalence and incidence of colorectal adenomas and cancer in asymptomatic persons. Gastro Endosc Clin North Am 1997; 7: 387-389.
2. Yokoyama N, Shirai Y, Wakai T, Nagakura S, Akazawa K, Hatakeyama K. Jaundice at presentation heralds advanced disease and poor prognosis in patients with AC. World J Surg 2005; 29: 519-523.
3. Beger HG, Treitschke F, Gansauge F, Harada N, Hiki N, Mattfeldt T. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg 1999; 134: 526-532.
4. Dorandeu A, Raoul JL, Siriser F, Leclercq-Rioux N, Gosselin M, Martin ED, et al. Carcinoma of the ampulla of Vater: prognostic factors after curative surgery: a series of 45 cases. Gut 1997; 40: 350-355.
5. Neoptolemos JP, Talbot IC, Shaw DC, Carr-Locke DL. Long-term survival after resection of AC is associated independently with tumor grade and a new staging classification that assesses local invasiveness. Cancer 1988; 61: 1403-1407.
6. Roder JD, Schneider PM, Stein HJ, Siewert JR. Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg 2005; 82: 1693-1696.
7. Yoon YS, Kim SW, Park SJ, Lee HS, Jang JY, Choi MG, et al. Clinicopathologic analysis of early Ampulla of Vater carcinomas with a focus on the feasibility of ampullectomy. Ann Surg 2005; 242: 92-100.
8. Winter JM, Cameron JL, Olino K, Herman JM, de Jong MC, Hruban RH, et al. Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg 2010; 14: 379-387.
9. Sommerville CA, Limongelli P, Pai M, Ahmad R, Stamp G, Habib NA, et al. Survival analysis after pancreatic resection for ampullary and pancreatic head carcinoma: an analysis of clinicopathological factors. J Surg Oncol 2009; 100: 651-656.
10. Yamaguchi K, Enjoji M, Kitamura K. Non-icteric AC with a favorable prognosis. Am J Gastroenterol 1990; 85: 994-999.
11. Harada N, Treitschke F, Imaizumi T, Beger HG. Pancreatic invasion is a prognostic indicator after radical resection for carcinoma of the ampulla of Vater. J Hepato-Biliary-Pancreatic Surg 1997; 4: 215-219.
12. Qiao QL, Zhao YG, Ye ML, Yang YM, Zhao JX, Huang YT, et al. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg 2007; 31: 137-143.
13. Hatzaras I, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol 2010; 17: 991-997.
14. Di Giorgio A, Alfieri S, Rotondi F, Prete F, Di Miceli D, Ridolfini MP, et al. Pancreatoduodenectomy for tumors of Vater's ampulla: report on 94 consecutive patients. World J Surg 2005; 29: 513-518.
15. Assimakopoulos SF, Scopa CD, Vagianos CE. Pathophysiology of increased intestinal permeability in obstructive jaundice. World J Gastroenterol 2007; 13: 6458-6464.
16. van der Gaag NA, Rauws EA, van Eijck CH, Bruno MJ, van der Harst E, Kubben FJ, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 2010; 362: 129-137.
17. Cao LP, Chen BW, Peng SY. Influence of jaundice on pancreatoduodenectomy (in Chinese). Chin J Hepatobiliary Surg 2006; 12: 444-446.
18. Feng J, Huang ZQ, Chen YL, Dong JH, Chen MY, Wang YS, et al. Influence of obstructive jaundice on postoperative complications and mortality after pancreaticoduodenectomy: analysis of the 25-year single-center data (in Chinese). Chin J Surg 2012; 50: 294-298.
19. Megison S, Dunn C, Horton J, Chao H. Effects of relief of biliary obstruction on mononuclear phagocyte system function and cell mediated immunity. Br J Surg 1991; 78: 568-571.
20. Koyama K, Takagi Y, Ito K, Sato T. Experimental and clinical studies on the effect of biliary drainage in obstructive jaundice. Am J Surg 1981; 142: 293-299.